Glaxo Operations UK Ltd — FDA Facility Profile

FEI 3003262904

Glaxo Operations UK Ltd is an FDA-registered facility (FEI 3003262904) located in Hertfordshire, GB. Registered operations: ANALYSIS; API MANUFACTURE; LABEL; MANUFACTURE; PACK; PARTICLE SIZE REDUCTION. RegDataLab tracks 8 FDA inspections at this facility.

Reviewing Glaxo Operations UK Ltd as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Glaxo Operations UK Ltd yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Dec 6, 2024: Voluntary Action Indicated (VAI)
Inspections on record
8 (5 VAI, 3 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Import refusals
10 or more

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Dec 6, 2024Voluntary Action Indicated (VAI)No citations listed
Sep 6, 2019Voluntary Action Indicated (VAI)Procedures for non-sterile drug products (21 CFR 211.113(a))
Jan 25, 2019Voluntary Action Indicated (VAI)No citations listed
Jul 10, 2015No Action Indicated (NAI)No citations listed
Sep 12, 2014No Action Indicated (NAI)No citations listed
Apr 25, 2013Voluntary Action Indicated (VAI)No citations listed
Mar 30, 2012Voluntary Action Indicated (VAI)Complaint Handling Procedure (21 CFR 211.198(a))
Control procedures to monitor and validate performance (21 CFR 211.110(a))
Scientifically sound laboratory controls (21 CFR 211.160(b))
Storage under appropriate conditions (21 CFR 211.142(b))
Jul 21, 2009No Action Indicated (NAI)No citations listed

Facility details

Company
Glaxo Operations UK Limited
Location
Hertfordshire (GB)
Registration Expires
Dec 31, 2026
Operations
ANALYSIS; API MANUFACTURE; LABEL; MANUFACTURE; PACK; PARTICLE SIZE REDUCTION
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.